Key facts
- It has raised $380K; the latest was Seed Round ($380K) in Oct 2025.
- Elite 7 Sports Medicine has filed 2 Form Ds with the SEC, most recently Oct 2025 ($225K sold to 6 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Elite 7 Sports Medicine
- ·The full record, as it builds
Funding rounds
No funding rounds for Elite 7 Sports Medicine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elite 7 Sports Medicine
Provider of multidisciplinary sport-specific care services intended to take care of athletes in youth and non-traditional sports across a series of national and regional events. The company provides comprehensive athletic medical care for high school, collegiate, amateur, and professional athletes across a wide range of traditional and non-traditional sports, enabling athletes to receive acute or chronic injury treatments, concussion management, preventative care, and other continuity of care services from licensed athlete trainers at affordable prices with increased flexibility and better pay.
- Sector
- Healthcare
- HQ
- Las Vegas, NV, United States
- Founded
- 2022
- Employees
- 4
- Website
- e7sportsmedicine.com/
- Ownership
- Privately Held (backing)
Elite 7 Sports Medicine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elite 7 Sports Medicine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elite 7 Sports Medicine in its N-PORT filings yet. We sweep new filings monthly.